Bibliometric Analysis of Research on Premature Adrenarche from 1974 to 2024
PDF
Cite
Share
Request
Research Article
VOLUME: 11 ISSUE: 1
P: 32 - 39
February 2026

Bibliometric Analysis of Research on Premature Adrenarche from 1974 to 2024

Cyprus J Med Sci 2026;11(1):32-39
1. Department of Pediatrics Hitit University Erol Olçok Training and Research Hospital, Çorum, Türkiye
No information available.
No information available
Received Date: 03.11.2025
Accepted Date: 09.12.2025
Online Date: 17.02.2026
Publish Date: 17.02.2026
PDF
Cite
Share
Request

Abstract

BACKGROUND/AIMS

Premature adrenarche (PA) is a clinical condition marked by early activation of adrenal androgens prior to puberty. Once regarded as a benign developmental variant, PA is now linked to long-term health risks such as metabolic syndrome, polycystic ovary syndrome (PCOS), and type 2 diabetes. This study aims to provide a comprehensive bibliometric analysis of scientific literature on PA published between 1974 and 2024.

MATERIALS AND METHODS

This descriptive bibliometric analysis included 445 publications indexed in the Scopus database under the search term “PA”. Publications were categorized by type, discipline, country, and institution. VOS viewer software was used to map keyword co-occurrence and citation networks to identify research trends and influential works.

RESULTS

Of all publications, 68.08% were original articles, 18.42% were reviews, and the remainder were book chapters or conference proceedings. The United States led with 186 publications, while Kuopio University Hospital emerged as the most prolific institution. The most frequently used keywords included “human,” “child,” and “adrenarche,” with “DHEAS” and “androgen” reflecting growing biochemical focus. The most-cited publication was a position statement addressing PCOS.

CONCLUSION

Although there has been a notable rise in PA-related research over the last five decades, key gaps remain, particularly concerning diagnostic standardization, long-term outcomes, and underrepresentation of developing countries. Interdisciplinary approaches, harmonized diagnostic protocols, and the integration of advanced technologies will be critical to improve research quality and clinical care. This bibliometric analysis offers a valuable roadmap for future research in this evolving domain of pediatric endocrinology.

Keywords:
Premature adrenarche, bibliometric analysis, citation analysis, keyword analysis, scientific mapping

INTRODUCTION

Premature adrenarche (PA) is a clinical condition resulting from early activation of the adrenal cortex, typically before 8 years of age in girls and 9 years of age in boys. It is characterized by increased secretion of adrenal androgen precursors, particularly dehydroepiandrosterone (DHEA) and its sulfate (DHEAS). Clinically, PA manifests with signs such as pubic or axillary hair development, oily skin, and acne. Fuller Albright first mentioned adrenal changes associated with early hormonal activity in 1947 in relation to osteoporosis.1 In 1952, Silverman, Migeon, Rosemberg, and Wilkins described the appearance of sexual hair in the absence of other secondary sexual traits, coining the term “premature pubarche” and suggesting that it may represent a constitutional variant of puberty.2

Initially considered a benign variation of normal development, PA may, according to subsequent research, serve as a precursor to more serious conditions such as metabolic syndrome (MetS), polycystic ovary syndrome (PCOS), and type 2 diabetes.3, 4 A central aspect of the pathophysiology of PA is the premature development of the adrenal zona reticularis, resulting in incomplete enzymatic maturation-especially of 3β-hydroxysteroid dehydrogenase-and subsequent increased production of DHEA and DHEAS.5, 6 Morphological studies of the adrenal cortex support this mechanism, showing a specific structural differentiation of the zona reticularis during adrenarche.6

Moreover, elevated DHEAS levels during PA have been recognized not merely as a transient biochemical variation but also as a potential biomarker for long-term endocrine and metabolic disturbances.7 PA is thus increasingly viewed as a multifactorial syndrome influenced by genetic, intrauterine, and environmental factors.8 For instance, Ibáñez et al.4 and colleagues demonstrated that girls born small for gestational age were at increased risk of PA, hyperinsulinemia, and subsequent ovarian hyperandrogenism. This supports the concept of fetal programming, where early growth restriction and compensatory postnatal insulin secretion contribute to adrenal hyperfunction.9

Children with PA also display an increased risk for obesity, insulin resistance, and lipid abnormalities, all of which are components of MetS.10, 11 Akinci et al.12 and colleagues observed that young women with a history of PA had a significantly higher prevalence of MetS, supporting the hypothesis that PA is not simply a transient variation in development but a marker of systemic risk. These hormonal alterations may influence multiple regulatory pathways, ultimately increasing the risk of cardiovascular disease and type 2 diabetes in adulthood.13, 14

PA is also associated with accelerated linear growth and advanced bone age during childhood. Utriainen et al.15found that girls with PA had significantly faster height velocity in early childhood, often resulting in compromised final height due to early epiphyseal fusion. Similarly, Ghizzoni and Milani16 described PA as a natural variant of adrenarche with variable outcomes depending on individual metabolic and hormonal contexts.

As the clinical implications of PA have broadened, so too has the scientific interest in this condition. The volume of research has grown considerably in recent decades, necessitating a structured evaluation of trends in publication activity and thematic development. Bibliometric analysis provides a powerful methodological framework for mapping scientific landscapes, identifying influential studies, authors, institutions, and research clusters.17-19

In this study, we conducted a bibliometric analysis of 445 articles indexed in Scopus from 1974 to 2024 using the keyword “PA.” The objective was to systematically examine the growth trajectory of PA-related literature, identify high-impact studies and collaborative networks, and analyze thematic clusters addressing etiology, clinical outcomes, genetic factors, and environmental factors. Through this structured approach, we aim to offer a comprehensive overview of scientific progress in PA and outline a roadmap for future research.20-25

MATERIALS AND METHODS

This study was conducted as a bibliometric analysis of previously published studies, and, as it does not involve human participants, an opinion was obtained from the Hitit University Ethics Committee stating that ethical committee approval was not required (02.07.2025; 2024/1974-2024).

This study utilized a bibliometric analysis approach to systematically examine the research landscape on PA between 1974 and 2024. Bibliometric analysis is a quantitative method used to evaluate scientific publications by measuring productivity, impact, and collaboration patterns within a specific research field. In this context, the method enables the identification of publication trends, influential authors, and thematic structures through citation data and keyword relationships. All bibliographic information was retrieved from the Scopus (Elsevier) database and analyzed using standard bibliometric indicators.

Statistical Analysis

All retrieved data were analyzed using descriptive statistical methods. Frequency and percentage distributions were calculated to summarize publication characteristics such as document type, publication year, and country of origin. Bibliometric mapping and visualization were performed using VOSviewer (version 1.6.20) to generate co-authorship, co-citation, and keyword co-occurrence networks. These maps were used to illustrate the intellectual and collaborative structure of the field. Data cleaning, tabulation, and graph generation were conducted in Microsoft Excel 2024. All analyses were descriptive in nature, and no inferential statistical tests were applied.

RESULTS

A total of 445 publications related to PA were identified in the Scopus database. The data revealed that the highest number of publications was recorded in 2024, with 22 studies. This was followed by 2012, 2015, 2022, and 2023 (each with 20 publications), and by 2017, 2018, and 2020 (each with 19 publications). Among these, 303 studies (68.08%) were journal articles, 82 (18.42%) were review articles, 26 (5.84%) were book chapters, 16 (3.59%) were conference papers, and 7 (1.57%) were letters (Table 1).

Active Institutions

In the field of PA, the most active institution was Kuopio University Hospital, with 29 publications. This was followed by Itä-Suomen Yliopisto, which contributed 27 publications (Table 2).

Active Journals

In the field of PA, the most prolific journal was the Journal of Clinical Endocrinology and Metabolism, which published 44 studies. It was followed by the Journal of Pediatric Endocrinology and Metabolism, which had 31 publications (Table 3).

Active Countries

In the field of PA, the United States was the most prominent contributor, with a total of 186 publications. This was followed by the United Kingdom, with 36 publications, and Finland, with 34 publications (Figures 1 and 2).

Most Cited Publications

The most cited study in the field of PA was “The polycystic ovary syndrome: A position statement from the European Society of Endocrinology,” which received 544 citations.26 This was followed by “Prader-Willi syndrome,” cited 493 times,27 and “Public health implications of altered puberty timing,” with 403 citations (Table 4).28

Research Areas with the Most Publications

The field of medicine accounted for the largest number of studies on PA, with a total of 411 publications. This was followed by biochemistry, genetics, and molecular biology, which encompassed 219 studies, and by neuroscience, which encompassed 8 studies (Figure 3).

Keyword Analysis and Trending Topics

A total of 801 keywords were identified across 445 publications extracted from the Scopus database spanning the years 1974 to 2024. Among these, 37 keywords were utilized in at least five publications. Network visualizations based on these keywords were presented in Figure 4. The visualizations revealed that prominent keywords were “human,” “female,” “adrenarche,” and “child.” In recent years, “DHEAS,” “androgen,” and “adrenarche” have emerged as prominent topics indicating a growing focus on these areas (Figure 4).

Thematic Content of Frequently Cited Studies

The content of the most frequently cited publications revealed key thematic focuses in PA research, including clinical presentation (e.g., early pubarche, growth patterns), hormonal evaluation (e.g., DHEA-S, androstenedione), imaging findings, differential diagnosis (e.g., congenital adrenal hyperplasia, PCOS), and psychosocial implications. These topics were predominantly observed in studies published after 2000, indicating an increasingly interdisciplinary approach.

DISCUSSION

This bibliometric analysis, covering a 50-year span from 1974 to 2024, systematically examined the scientific landscape surrounding PA, revealing important academic trends and critical gaps in the literature. The findings highlighted the dominance of clinical disciplines, geographical disparities in research output, evolving thematic focuses, and emergent directions for future inquiry.

Dominance of Medical Research in Premature Adrenarche Studies

A striking majority of the literature on PA (411 of 445 publications) originated within the medical field, reflecting its central relevance to pediatric endocrinology and metabolic health. This concentration underscores the clinical framing of PA as a disorder with diagnostic and therapeutic implications. However, contributions from fields such as neuroscience, molecular biology, and psychology remain sparse, leaving significant gaps in our understanding of the neuroendocrine mechanisms and psychosocial outcomes associated with PA. For instance, according to the World Health Organization (WHO), insulin resistance and early-onset MetSs often originate in childhood neuroendocrine dysregulation, indicating the need for a broader, interdisciplinary approach to comprehensively investigate PA.

Geographical Trends and Research Leadership

The United States led the global research effort with 186 publications, likely reflecting its extensive biomedical research infrastructure. The United Kingdom (36 publications) and Finland (34 publications) followed, with notable contributions from institutions such as Kuopio University Hospital and the University of Eastern Finland.

The prominent role of Finland suggests the effectiveness of focused national research funding in driving output in niche fields. Conversely, the limited participation from developing countries may reflect disparities in research resources and collaboration networks. This imbalance underscores the importance of promoting global equity in research by supporting underrepresented regions.

Publication Types and Citation Patterns

Analysis revealed that 68% of the PA literature were original research articles, while 18% were review articles, indicating both active data generation and a growing interest in synthesizing existing knowledge. Foundational contributions such as Conway et al.26 study on PCOS-cited over 500 times-demonstrate how PA intersects with broader endocrinological disorders like MetS and reproductive dysfunctions.6 Such high-impact publications serve as intellectual anchors within the field and shape subsequent research directions.

Keyword Dynamics and Emerging Themes

Keyword analysis indicated that the most frequently used terms were “human,” “child,” and “adrenarche,” underscoring the clinical and demographic focus of the literature. In parallel, emerging biochemical themes, such as DHEAS and androgens, reflect a heightened interest in the hormonal biomarkers of PA. The emergence of COVID-19 among the trending keywords also suggests an evolving contextualization of PA in relation to recent environmental and societal stressors. This shift aligns with growing research on how the pandemic has influenced pediatric endocrine disorders through altered routines, stress, and diet.7, 8

Gaps in the Literature and Future Research Directions

Despite substantial advancements, significant gaps persist in the PA literature. Most notably, the long-term health outcomes of individuals with a history of PA remain poorly documented. While several cross-sectional studies have linked PA to increased risks of insulin resistance, abdominal obesity, dyslipidemia, and type 2 diabetes in later life,4, 8, 10, 13, 14, 35-37 these findings are based on limited follow-up data. The need for long-term, prospective cohort studies is urgent.

According to WHO reports, early-onset metabolic and endocrine conditions, such as PA, may predispose individuals to lifelong health risks. However, the literature remains limited in establishing direct connections between childhood PA and adult cardiovascular morbidity, hypertension, or psychiatric comorbidities.

The neuroendocrine and psychosocial consequences of PA are similarly under-researched. The effects of early androgen exposure on emotional regulation, behavior, and cognitive development remain poorly understood.3, 37-39 The possible interaction between elevated DHEAS levels and the GABAergic system in the brain calls for interdisciplinary investigations combining endocrinology, psychiatry, and neuroscience.

Diagnostic variability also poses a barrier to clinical standardization. Many studies rely solely on clinical signs and DHEAS measurements to define PA, yet these parameters can vary with age, pubertal status, ethnicity, and environmental influences.5, 6, 40-42 There is a critical need for consensus-based diagnostic criteria and age-specific reference ranges.

Moreover, therapeutic approaches to PA remain ambiguous. Often dismissed as a benign developmental variant, PA is rarely targeted for early intervention. Yet, accumulating evidence suggests that early metabolic or hormonal interventions may yield long-term benefits in selected cases.12, 25, 43 Multicenter randomized controlled trials are therefore essential to evaluate the efficacy and safety of such interventions.

Future research on PA should prioritize several strategic directions to address the current gaps in knowledge. First, genetic and epigenetic profiling must be advanced, particularly through studies that investigate polymorphisms in steroidogenesis-related genes such as CYP21A2 and CYP11B1, which may clarify the genetic underpinnings of PA.44, 45 Second, the emerging role of gut microbiota in endocrine function suggests that longitudinal studies are warranted to explore the relationship between PA, microbial dysbiosis, and chronic systemic inflammation.46, 47 Third, the application of artificial intelligence and advanced data modeling holds promise for refining early diagnostic tools and improving risk stratification. Machine learning techniques, leveraging large datasets, could facilitate the development of predictive algorithms for early PA detection and prognosis.20, 24, 48 Fourth, given the suspected neuroendocrine effects of early androgen exposure, psychological and cognitive assessments should be incorporated into longitudinal cohort studies. These would help elucidate potential neurodevelopmental consequences of PA using validated cognitive and behavioral instruments.37, 39 Lastly, the establishment of global, multicenter collaborative research networks is essential. Such networks would not only allow for more comprehensive and diverse data collection but also promote equity in scientific representation, ensuring that findings are generalizable across geographic and socioeconomic boundaries. In sum, future research on PA must evolve toward a more integrative, multidisciplinary, and globally inclusive framework. Such an approach will not only deepen our understanding of PA’s complex etiology but also improve clinical practices, early detection, and prevention strategies across diverse populations.

Study Limitations

While this study provides a comprehensive overview of the scientific literature on PA, certain limitations should be acknowledged to ensure transparency. The analysis was based exclusively on records indexed in the Scopus database, which may not fully represent publications listed in other databases such as PubMed or Web of Science. As with all bibliometric studies, the results reflect patterns of publication and citation rather than the qualitative depth of the research content.
Nevertheless, the use of a major, multidisciplinary database such as Scopus and the application of established bibliometric tools (VOSviewer) provide a robust and representative view of global research activity in this field. Future studies may further enhance these findings by incorporating multiple databases or by integrating bibliometric mapping with qualitative content analyses.

CONCLUSION

This bibliometric analysis of 445 publications on PA over the past five decades reveals a growing but uneven body of research, largely concentrated in developed countries and primarily within pediatric endocrinology. Despite emerging evidence linking PA to long-term risks such as MetS, insulin resistance, and PCOS, the literature is limited by inconsistent diagnostic criteria, scarce longitudinal data, and minimal interdisciplinary integration. Future studies should adopt harmonized methodologies, include underrepresented populations, and explore emerging areas such as neuropsychological outcomes, genetic and epigenetic factors, and AI-driven analytics. A multidimensional and globally inclusive approach is essential to advance clinical care and long-term health outcomes related to PA.

MAIN POINTS

• This study presents the first comprehensive bibliometric analysis of premature adrenarche (PA) research covering the period 1974-2024, encompassing 445 publications indexed in the Scopus database.

• The analysis identified a steady increase in publication activity over the last two decades, with the United States, United Kingdom, and Finland emerging as leading contributors.

• Keyword co-occurrence and citation network analyses revealed key research foci concerning dehydroepiandrosterone sulfate, androgens, and metabolic outcomes, reflecting a growing biochemical and clinical orientation.

• The findings highlight persistent gaps in diagnostic standardization, long-term follow-up studies, and contributions from developing countries.

• This study provides a quantitative foundation and research roadmap for future interdisciplinary investigations into the pathophysiology, diagnosis, and long-term outcomes of PA.

Ethics

Ethics Committee Approval: This study was conducted as a bibliometric analysis of previously published studies, and, as it does not involve human participants, an opinion was obtained from the Hitit University Ethics Committee stating that ethical committee approval was not required (02.07.2025; 2024/1974-2024).
Informed Consent: Not applicable, as this study is a bibliometric analysis of previously published literature.
Financial Disclosure: The author declared that this study had received no financial support.

References

1
Albright F. Annals of internal medicine, Volume 27, 1947: Osteoporosis. Nutr Rev. 1989; 47(3): 85-6.
2
SILVERMAN SH, MIGEON C, ROSEMBERG E, WILKINS L. Precocious growth of sexual hair without other secondary sexual development; premature pubarche, a constitutional variation of adolescence. Pediatrics. 1952; 10(4): 426-32.
3
Williams RM, Ward CE, Hughes IA. Premature adrenarche. Arch Dis Child. 2012; 97(3): 250-4.
4
Ibáñez L, Potau N, Francois I, de Zegher F. Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab. 1998; 83(10): 3558-62.
5
Ibáñez L, Dimartino-Nardi J, Potau N, Saenger P. Premature adrenarche--normal variant or forerunner of adult disease? Endocr Rev. 2000; 21(6): 671-96.
6
Gell JS, Carr BR, Sasano H, Atkins B, Margraf L, Mason JI, et al. Adrenarche results from development of a 3beta-hydroxysteroid dehydrogenase-deficient adrenal reticularis. J Clin Endocrinol Metab. 1998; 83(10): 3695-701.
7
Orentreich N, Brind JL, Rizer RL, Vogelman JH. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab. 1984; 59(3): 551-5.
8
Codazzi V, Frontino G, Galimberti L, Giustina A, Petrelli A. Mechanisms and risk factors of metabolic syndrome in children and adolescents. Endocrine. 2024; 84(1): 16-28.
9
Bhunu B, Riccio I, Intapad S. Insights into the mechanisms of fetal growth restriction-induced programming of hypertension. Integr Blood Press Control. 2021; 14: 141-52.
10
Utriainen P, Jääskeläinen J, Romppanen J, Voutilainen R. Childhood metabolic syndrome and its components in premature adrenarche. J Clin Endocrinol Metab. 2007; 92(11): 4282-5.
11
Weiss R. Metabolic syndrome in childhood - causes and effects. Endocr Dev. 2010; 19: 62-72.
12
Akinci G, Coskun S, Akinci B, Hekimsoy Z, Bayindir P, Onur E, et al. Atherosclerosis risk factors in children of parents with the metabolic syndrome. Atherosclerosis. 2007; 194(2): e165-71.
13
Neeland IJ, Lim S, Tchernof A, Gastaldelli A, Rangaswami J, Ndumele CE, et al. Metabolic syndrome. Nat Rev Dis Primers. 2024; 10(1): 77.
14
Lazar L, Pollak U, Kalter-Leibovici O, Pertzelan A, Phillip M. Pubertal course of persistently short children born small for gestational age (SGA) compared with idiopathic short children born appropriate for gestational age (AGA). Eur J Endocrinol. 2003; 149(5): 425-32.
15
Utriainen P, Voutilainen R, Jääskeläinen J. Girls with premature adrenarche have accelerated early childhood growth. J Pediatr. 2009; 154(6): 882-7.
16
Ghizzoni L, Milani S. The natural history of premature adrenarche. J Pediatr Endocrinol Metab. 2000; 13 Suppl 5: 1247-51.
17
Donthu N, Kumar S, Mukherjee D, Pandey N, Lim WM. How to conduct a bibliometric analysis: an overview and guidelines. Journal of Business Research. 2021; 133: 285-96.
18
Aria M, Cuccurullo C. Bibliometrix: an R-tool for comprehensive science mapping analysis. Journal of Informetrics. 2017; 11(4): 959-75.
19
Koç F. Bibliometric analysis of research in the field of evolutionary psychology between 1894 and 2024. Çukurova Üniversitesi Sosyal Bilimler Enstitüsü Dergisi. 2025; 34(2): 1540-56.
20
Ellegaard O, Wallin JA. The bibliometric analysis of scholarly production: how great is the impact? Scientometrics. 2015; 105(3): 1809-31.
21
Glänzel W. Bibliometrics as a research field: a course on theory and application of bibliometric indicators. Scientometrics. 2003; 57(2): 357-69.
22
Bornmann L, Leydesdorff L. Scientometrics in a changing research landscape: bibliometrics has become an integral part of research quality evaluation and has been changing the practice of research. EMBO Rep. 2014; 15(12): 1228-32.
23
Ibáñez L, Ong KK, López-Bermejo A, Dunger DB, de Zegher F. Hyperinsulinaemic androgen excess in adolescent girls. Nat Rev Endocrinol. 2014; 10(8): 499-508.
24
Reiter EO, Rosenfeld RG. Normal and aberrant growth. Endocrinology and Metabolism Clinics of North America. 2003; 32(1): 175-200.
25
Tennilä J, Jääskeläinen J, Utriainen P, Voutilainen R, Laitinen T, Liimatta J. Cardiorespiratory fitness in young adult women with a history of premature adrenarche. J Endocr Soc. 2023; 7(5): bvad041.
26
Conway G, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Franks S, Gambineri A, et al. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur J Endocrinol. 2014; 171(4) :P1-29.
27
Cassidy SB, Schwartz S, Miller JL, Driscoll DJ. Prader-Willi syndrome. Genet Med. 2012; 14(1): 10-26.
28
Golub MS, Collman GW, Foster PM, Kimmel CA, Rajpert-De Meyts E, Reiter EO, et al. Public health implications of altered puberty timing. Pediatrics. 2008; 121 Suppl 3: S218-30.
29
Wakeling EL, Brioude F, Lokulo-Sodipe O, O’Connell SM, Salem J, Bliek J, et al. Diagnosis and management of Silver-Russell syndrome: first international consensus statement. Nat Rev Endocrinol. 2017; 13(2): 105-24.
30
Rosenfield RL. Clinical review: Identifying children at risk for polycystic ovary syndrome. J Clin Endocrinol Metab. 2007; 92(3): 787-96.
31
Auchus RJ, Rainey WE. Adrenarche - physiology, biochemistry and human disease. Clin Endocrinol (Oxf). 2004; 60(3): 288-96.
32
Longo S, Bollani L, Decembrino L, Di Comite A, Angelini M, Stronati M. Short-term and long-term sequelae in intrauterine growth retardation (IUGR). J Matern Fetal Neonatal Med. 2013; 26(3): 222-5.
33
Sizonenko PC, Paunier L. Hormonal changes in puberty III: correlation of plasma dehydroepiandrosterone, testosterone, FSH, and LH with stages of puberty and bone age in normal boys and girls and in patients with Addison’s disease or hypogonadism or with premature or late adrenarche. J Clin Endocrinol Metab. 1975; 41(5): 894-904.
34
Havelock JC, Auchus RJ, Rainey WE. The rise in adrenal androgen biosynthesis: adrenarche. Semin Reprod Med. 2004; 22(4): 337-47.
35
Ben Said W, Lempesis IG, Fernandez-Garcia S, Thangaratinam S, Arlt W, Idkowiak J. Premature adrenarche and metabolic risk: a systematic review and meta-analysis. Eur J Endocrinol. 2025; 193(3): S1-14.
36
Farahmand M, Tehrani FR, Dovom MR, Azizi F. Menarcheal age and risk of type 2 diabetes: a community-based cohort study. J Clin Res Pediatr Endocrinol. 2017; 9(2): 156-62.
37
Boddu SK, Giannini C, Marcovecchio ML. Metabolic disorders in young people around the world. Diabetologia. 2025; 68(11): 2374-85.
38
Tissot A, Dorn LD, Rotenstein D, Rose SR, Sontag-Padilla LM, Jillard CL, et al. Neuropsychological functioning in girls with premature adrenarche. J Int Neuropsychol Soc. 2012; 18(1): 151-6.
39
Paulus FW, Ohmann S, Möhler E, Plener P, Popow C. Emotional dysregulation in children and adolescents with psychiatric disorders. A narrative review. Front Psychiatry. 2021; 12: 628252.
40
Tennilä J, Muukkonen L, Utriainen P, Voutilainen R, Jääskeläinen J, Liimatta J. Cognitive performance in young adult women with a history of premature adrenarche. Pediatr Res. 2025; 97(2): 714-22.
41
Voutilainen R, Jääskeläinen J. Premature adrenarche: etiology, clinical findings, and consequences. J Steroid Biochem Mol Biol. 2015; 145: 226-36.
42
Rosenfield RL. Normal and premature adrenarche. Endocr Rev. 2021; 42(6): 783-814.
43
Carnevali O, Hardiman G editors. Environmental Contaminants and Endocrine Health. Academic Press. 2023.
44
Liimatta J, du Toit T, Voegel CD, Jääskeläinen J, Lakka TA, Flück CE. Multiple androgen pathways contribute to the steroid signature of adrenarche. Mol Cell Endocrinol. 2024; 592: 112293.
45
Krishna KB, Witchel SF. Normal and Abnormal Puberty. 2024. In: Feingold KR, Adler RA, Ahmed SF, Anawalt B, Blackman MR, Chrousos G, et al, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–.
46
Martinez-Arguelles DB, Papadopoulos V. Epigenetic regulation of the expression of genes involved in steroid hormone biosynthesis and action. Steroids. 2010; 75(7): 467-76.
47
Marano G, Rossi S, Sfratta G, Acanfora M, Anesini MB, Traversi G, et al. Gut microbiota in women with eating disorders: a new frontier in pathophysiology and Treatment. Nutrients. 2025; 17(14): 2316.
48
Agnani H, Bachelot G, Eguether T, Ribault B, Fiet J, Le Bouc Y, et al. A proof of concept of a machine learning algorithm to predict late-onset 21-hydroxylase deficiency in children with premature pubic hair. J Steroid Biochem Mol Biol. 2022; 220: 106085.